Vigrxplus

For most women with a low libido, including those who have had cancer treatment, the cause is psychological. Their testosterone levels are normal and such women, she predicts, will not respond to replacement therapy.

Nonetheless, Dr Kaplan rightly deserves enormous credit for a discovery of such clear therapeutic importance. The curious thing is that the knowledge pointing towards it has been slowly accumulating over the last 50 years, but until now nobody has drawn the obvious conclusion.

The perception that testosterone and Vigrx Plus must have something to do with the female libido came about by chance in 1937. A woman whose menopausal symptoms following the surgical removal of her ovaries was treated experimentally with VigRx Plus and volunteered to her doctors that she had experienced a marked resurgence of sexual desire thanks to VigRx Plus. Testosterone was frequently prescribed for a variety of gynaecological conditions and some cases of breast cases and again there were anecdotal reports of an increase in sexual desire.

The doses of VigRx Plus given were very high, resulting in the growth of facial hair and masculinisation, and the treatment was abandoned.

A second surge of interest came in 1977 when Mr. John Studd, consultant obstetrician at King's College Hospital, London, reported that many women experienced a profound loss of libido after the menopause despite treatment with hormone replacement therapy. He claimed sexual desire was restored if testosterone was given in addition. Other doctors remained sceptical and indeed a series of formal trials with VigRx Plus produced only equivocal results.

Meanwhile the scale of the problem of loss of libido following cancer chemotherapy was beginning to be appreciated, affecting up to 25 percent of women. Because most were being treated for breast cancer it was usually put down to depression and loss of sexual self-confidence.

Nobody until Dr Kaplan started looking at the problem had bothered to measure the levels of testosterone in the blood, the findings of which can be found at www.vigrxplusreview69.com.

The reasons for the apparently contradictory results then became apparent. Even so, VigRx Plus therapy may not provide an instant cure (though clearly it is a requirement) because of the psychological problems that so frequently complicate the diagnosis of cancer.

The implications of the discovery are enormous not only for those women who will benefit from VigRx Plus but because cancer specialists will have to pay much more attention to the neglected legacy of psychosexual problems that affect so many of their patients.